204 related articles for article (PubMed ID: 21368289)
1. Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells.
Weichhart T; Haidinger M; Katholnig K; Kopecky C; Poglitsch M; Lassnig C; Rosner M; Zlabinger GJ; Hengstschläger M; Müller M; Hörl WH; Säemann MD
Blood; 2011 Apr; 117(16):4273-83. PubMed ID: 21368289
[TBL] [Abstract][Full Text] [Related]
2. The TSC-mTOR signaling pathway regulates the innate inflammatory response.
Weichhart T; Costantino G; Poglitsch M; Rosner M; Zeyda M; Stuhlmeier KM; Kolbe T; Stulnig TM; Hörl WH; Hengstschläger M; Müller M; Säemann MD
Immunity; 2008 Oct; 29(4):565-77. PubMed ID: 18848473
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells.
Varga G; Ehrchen J; Tsianakas A; Tenbrock K; Rattenholl A; Seeliger S; Mack M; Roth J; Sunderkoetter C
J Leukoc Biol; 2008 Sep; 84(3):644-50. PubMed ID: 18611985
[TBL] [Abstract][Full Text] [Related]
4. Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice.
Hurez V; Dao V; Liu A; Pandeswara S; Gelfond J; Sun L; Bergman M; Orihuela CJ; Galvan V; Padrón Á; Drerup J; Liu Y; Hasty P; Sharp ZD; Curiel TJ
Aging Cell; 2015 Dec; 14(6):945-56. PubMed ID: 26315673
[TBL] [Abstract][Full Text] [Related]
5. Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway.
Sahan-Firat S; Temiz-Resitoglu M; Guden DS; Kucukkavruk SP; Tunctan B; Sari AN; Kocak Z; Malik KU
Inflammation; 2018 Feb; 41(1):276-298. PubMed ID: 29110153
[TBL] [Abstract][Full Text] [Related]
6. NFκB- and MAP-Kinase Signaling Contribute to the Activation of Murine Myeloid Dendritic Cells by a Flagellin A:Allergen Fusion Protein.
Moeller T; Wolfheimer S; Goretzki A; Scheurer S; Schülke S
Cells; 2019 Apr; 8(4):. PubMed ID: 30991709
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone counteracts the immunostimulatory effects of triiodothyronine (T3) on dendritic cells.
Montesinos MM; Alamino VA; Mascanfroni ID; Susperreguy S; Gigena N; Masini-Repiso AM; Rabinovich GA; Pellizas CG
Steroids; 2012 Jan; 77(1-2):67-76. PubMed ID: 22056479
[TBL] [Abstract][Full Text] [Related]
8. Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice.
Makki K; Taront S; Molendi-Coste O; Bouchaert E; Neve B; Eury E; Lobbens S; Labalette M; Duez H; Staels B; Dombrowicz D; Froguel P; Wolowczuk I
PLoS One; 2014; 9(4):e92684. PubMed ID: 24710396
[TBL] [Abstract][Full Text] [Related]
9. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
[TBL] [Abstract][Full Text] [Related]
10. Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells.
Liu G; Bi Y; Wang R; Yang H; Zhang Y; Wang X; Liu H; Lu Y; Zhang Z; Chen W; Chu Y; Yang R
J Immunol; 2014 Apr; 192(7):3068-79. PubMed ID: 24567529
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis.
Gu L; Gao J; Li Q; Zhu YP; Jia CS; Fu RY; Chen Y; Liao QK; Ma Z
Leukemia; 2008 Nov; 22(11):2091-6. PubMed ID: 18685609
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids promote apoptosis of proinflammatory monocytes by inhibiting ERK activity.
Achuthan A; Aslam ASM; Nguyen Q; Lam PY; Fleetwood AJ; Frye AT; Louis C; Lee MC; Smith JE; Cook AD; Olshansky M; Turner SJ; Hamilton JA
Cell Death Dis; 2018 Feb; 9(3):267. PubMed ID: 29449600
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway.
Chen W; Ma T; Shen XN; Xia XF; Xu GD; Bai XL; Liang TB
Cancer Res; 2012 Mar; 72(6):1363-72. PubMed ID: 22287548
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IFN-gamma signaling by glucocorticoids.
Hu X; Li WP; Meng C; Ivashkiv LB
J Immunol; 2003 May; 170(9):4833-9. PubMed ID: 12707366
[TBL] [Abstract][Full Text] [Related]
15. mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells.
Huijts CM; Schneiders FL; Garcia-Vallejo JJ; Verheul HM; de Gruijl TD; van der Vliet HJ
J Immunol; 2015 Sep; 195(5):2038-45. PubMed ID: 26238486
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression.
Woltman AM; van der Kooij SW; Coffer PJ; Offringa R; Daha MR; van Kooten C
Blood; 2003 Feb; 101(4):1439-45. PubMed ID: 12393532
[TBL] [Abstract][Full Text] [Related]
17. mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.
Johnson SC; Martinez F; Bitto A; Gonzalez B; Tazaerslan C; Cohen C; Delaval L; Timsit J; Knebelmann B; Terzi F; Mahal T; Zhu Y; Morgan PG; Sedensky MM; Kaeberlein M; Legendre C; Suh Y; Canaud G
Kidney Int; 2019 Feb; 95(2):455-466. PubMed ID: 30471880
[TBL] [Abstract][Full Text] [Related]
18. Combined OX40L and mTOR blockade controls effector T cell activation while preserving T
Tkachev V; Furlan SN; Watkins B; Hunt DJ; Zheng HB; Panoskaltsis-Mortari A; Betz K; Brown M; Schell JB; Zeleski K; Yu A; Kirby I; Cooley S; Miller JS; Blazar BR; Casson D; Bland-Ward P; Kean LS
Sci Transl Med; 2017 Sep; 9(408):. PubMed ID: 28931653
[TBL] [Abstract][Full Text] [Related]
19. Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells.
López-Royuela N; Balsas P; Galán-Malo P; Anel A; Marzo I; Naval J
Biochim Biophys Acta; 2010 Feb; 1803(2):311-22. PubMed ID: 19914305
[TBL] [Abstract][Full Text] [Related]
20. A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation.
Haidinger M; Poglitsch M; Geyeregger R; Kasturi S; Zeyda M; Zlabinger GJ; Pulendran B; Hörl WH; Säemann MD; Weichhart T
J Immunol; 2010 Oct; 185(7):3919-31. PubMed ID: 20805416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
